- The Fed will be growing its balance sheet again, but don’t call it ‘QE4’ (CNBC)
- James Bullard says the Fed still has a ‘little more to go’ with rate cuts (CNBC)
- Hedge Fund and Insider Trading News: Tiger Global Management, Elliott Management, Aldeyra Therapeutics Inc (ALDX), Restoration Hardware Holdings, Inc (RH), and More (Insider Monkey)
- Drug-Price Legislation Unlikely Before Election, Analyst Says (Barron’s)
- China says in close communication with U.S. over October trade talks (Reuters)
- Netflix Stock Has Taken a Beating. Here’s How to Play a Bounceback. (Barron’s)
- Trump Announces a Trade Pact With Japan (New York Times)
- Latinos may be the key to future US economic growth, study argues (CNBC)
- AbbVie Is Up After Another Analyst Reconsidered Its Allergan Acquisition and Upgraded the Stock (Barron’s)
- Wells Fargo acting chief Parker likely to get job by default (Yahoo! Finance)
- Despite Setbacks, Biogen is a Buy for Value Investors (Yahoo! Finance)
- 4 Blue-Chip Large-Cap Stocks That All Yield a Massive 7% or More (24/7 Wall Street)
- Millennials Continue to Leave Big Cities (Wall Street Journal)
- Trump Says Impeachment Could Derail U.S.-Mexico-Canada Trade Deal (Wall Street Journal)
- An Unimpeachable Reason to Buy Stocks (Wall Street Journal)
